Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 4/20 | 0.46 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.43 |
| ▸ | REN | P00797 | 1/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 4/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.40 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | CTSE | P14091 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31232524 | 0.91 | CAPN1 (0.46) | CALCRLCAPN1RENXIAPNTSR2 | |
| SCHEMBL30239989 | 0.87 | XIAP (0.49) | CAPN1RENXIAPDPP4DPP8 | |
| SCHEMBL31040327 | 0.87 | CALCRL (0.50) | CALCRLCAPN1RENXIAPNTSR2 | |
| SCHEMBL31568001 | 0.86 | CAPN1 (0.51) | CALCRLCAPN1RENXIAPOPRK1 | |
| SCHEMBL30399601 | 0.85 | ACE (0.45) | RENDPP4DPP8DPP9DPP7 | |
| SCHEMBL30069147 | 0.85 | DPP4 (0.50) | RENXIAPDPP4DPP8DPP9 | |
| SCHEMBL31518648 | 0.84 | DPP4 (0.52) | RENXIAPDPP4DPP8DPP9 | |
| SCHEMBL30399992 | 0.84 | OPRK1 (0.49) | CALCRLOPRK1NTSR2NTSR1SORT1 | |
| SCHEMBL30596290 | 0.84 | CALCRL (0.51) | CALCRLCAPN1RENOPRK1CTSD | |
| SCHEMBL30553111 | 0.83 | CAPN1 (0.47) | CAPN1RENXIAPCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3993784-A1 | COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS | Accure Therapeutics, S.L. (ES) | 2022-05-11 | — | — | EP | disclosed |